Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Using proprietary copolymer technology, TEV-’749 allows for a controlled steady release of olanzapine, a second generation antipsychotic.
Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, ...
The U.S. Food and Drug Administration has approved a highly effective HIV prevention drug that outperforms oral medications in stopping HIV transmission. Developed by Gilead Sciences, the drug ...
Zydus Lifesciences will roll out generic semaglutide injections in India post-patent expiry, using a reusable single-pen ...
The Healthy @Reader's Digest on MSN
16,500 critical fertility drugs recalled nationwide
Fortunately, a fix should be relatively simple for most.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results